Cargando…
Proposed Mechanisms of Targeting COVID-19 by Delivering Mesenchymal Stem Cells and Their Exosomes to Damaged Organs
With the outbreak of coronavirus disease (COVID-19) caused by novel severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the world has been facing an unprecedented challenge. Considering the lack of appropriate therapy for COVID-19, it is crucial to develop effective treatments instead of s...
Autores principales: | Jamshidi, Elham, Babajani, Amirhesam, Soltani, Pegah, Niknejad, Hassan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer US
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7799400/ https://www.ncbi.nlm.nih.gov/pubmed/33432484 http://dx.doi.org/10.1007/s12015-020-10109-3 |
Ejemplares similares
-
Recent Advances on Drug-Loaded Mesenchymal Stem Cells With Anti-neoplastic Agents for Targeted Treatment of Cancer
por: Babajani, Amirhesam, et al.
Publicado: (2020) -
Targeted Mitochondrial Therapy With Over-Expressed MAVS Protein From Mesenchymal Stem Cells: A New Therapeutic Approach for COVID-19
por: Babajani, Amirhesam, et al.
Publicado: (2021) -
Anti-cancer effects of human placenta-derived amniotic epithelial stem cells loaded with paclitaxel on cancer cells
por: Babajani, Amirhesam, et al.
Publicado: (2022) -
Mesenchymal Stem Cell-Derived Antimicrobial Peptides as Potential Anti-Neoplastic Agents: New Insight into Anticancer Mechanisms of Stem Cells and Exosomes
por: Moeinabadi-Bidgoli, Kasra, et al.
Publicado: (2022) -
Human placenta-derived amniotic epithelial cells as a new therapeutic hope for COVID-19-associated acute respiratory distress syndrome (ARDS) and systemic inflammation
por: Babajani, Amirhesam, et al.
Publicado: (2022)